Paxlovid does not increase risk of COVID reinfection: study

Published Date: 16 Feb 2023

Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.

2.

Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?

3.

How to keep your prostate healthy and lower your risk of developing serious problems

4.

Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training

5.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot